CA

Catalio Capital Management — Seed & Series A VC Firm ($250K–$5.0M Checks)

VC
Baltimore, MDProfile updated November 2026Website

Catalio Capital Management is a Seed, Series A venture capital firm based in Baltimore, MD investing in Healthcare. The firm typically writes $250K–$5.0M checks and has 46 portfolio companies in our records.

Check size
$250K–$5.0M
Portfolio
46 companies on record
Partners
10 listed
AUM
$2B
Stage
Seed, Series A
Sectors
Healthcare
HQ
Baltimore, MD

Last verified: 2026-07-14

How to approach: warm intro preferred
Stage

Seed, Series A

Check Size

$250K – $5.0M

AUM

$2.0B

Portfolio

46+ companies

Team

10 partners

Investor activity
Last known investment: 2025

About Catalio Capital Management

Catalio Capital Management is a venture capital firm headquartered in Baltimore, MD. The firm invests in companies developing breakthrough life sciences and healthcare innovations. Catalio Capital Management focuses on the Life Sciences and Healthcare sectors and does not invest in Consumer or Media.

The firm typically participates in seed and series A stages with check sizes ranging from $250K to $5.0M. Catalio Capital Management has $2B in assets under management. Warm introductions are preferred. The firm is led by a team that includes George Petrocheilos, Co-Founder and Managing Partner with focus on Life Sciences and Healthtech, along with Isaac Ro, Sofia Marsaglia, Will Denehy, Olga Maltseva, John Iucker, Ben Snedeker, Diamantis Xylas, Tom Brooks, and Sarah Saraiva.

Investment Thesis

Invests in companies developing breakthrough life sciences and healthcare innovations.

How Catalio Capital Management invests

Catalio Capital Management is a vc firm based in Baltimore, MD. The firm invests at the Seed, Series A stages, with a focus on Healthcare. It does not invest in Consumer, Media.

Catalio Capital Management typically writes checks of $250K–$5.0M per investment, backed by approximately $2B in assets under management.

Investing since at least 2020, Catalio Capital Management has backed 46 companies in our records, including audicus, pillar biosciences, paige. Its most recent recorded investment was in 2025.

Partners & Team

IR

Isaac Ro

Partner

SM

Sofia Marsaglia

Director of Impact

WD

Will Denehy

Vice President

OM

Olga Maltseva

Chief Operating Officer

JI

John Iucker

General Partner

BS

Ben Snedeker

Co-Head of Public Equities

DX

Diamantis Xylas

Director of Research

TB

Tom Brooks

General Partner

SS

Sarah Saraiva

Finance Director

GP

George Petrocheilos

Co-Founder & Managing Partner

Life Sciences
Healthtech

Industry Focus

Invests In

Healthcare

Does Not Invest In

Consumer
Media

Recent Activity

Invested in sickbay

2025 · portfolio records

Invested in pillar biosciences

2025 · portfolio records

Invested in paige

2025 · portfolio records

Invested in audicus

2025 · portfolio records

Invested in ensoma

2024 · portfolio records

Invested in dianthus

2024 · portfolio records

Invested in arrivent

2024 · portfolio records

Invested in neumora

2023 · portfolio records

Investment Track Record

Catalio Capital Management has recorded investments in 46 portfolio companies. The firm's earliest recorded investment year is 2020 and most recent is 2025. Recorded investments include companies such as audicus, paige, pillar biosciences, sickbay, arrivent, dianthus, ensoma, haystack oncology, neumora, pgdx, atai life sciences, recursion, compass, thrive sciences, and AVAVA across Biotechnology, Healthcare, and related subsectors.

Many of these companies have achieved liquidity events including IPOs for arrivent, dianthus, neumora, atai life sciences, recursion, and compass as well as exits for haystack oncology, pgdx, and thrive sciences. Additional transactions include loan repayments, M&A, and a financing round with equity plus debt.

Portfolio Companies (46)

2025

AU

audicus

Healthcare·Loan Repayment
PI

pillar biosciences

Biotechnology·Loan Repayment
PA

paige

Healthcare·M&A
SI

sickbay

Healthcare·Loan Repayment

2024

DI

dianthus

Biotechnology·IPO
AR

arrivent

Biotechnology·IPO
EN

ensoma

Biotechnology·Loan Repayment

2023

HA

haystack oncology

Healthcare·Exit
NE

neumora

Biotechnology·IPO

2022

PG

pgdx

Healthcare·Exit
How to pitch Catalio Capital Management
  • •Raising at Seed, Series A? You're squarely in their sweet spot.
  • •Lead with your fit in Healthcare — the sectors they actively back.
  • •Size your ask to their typical $250K – $5.0M check.
  • •warm intro preferred
  • •Address your outreach to a specific partner, such as Isaac Ro, Partner.
  • •A warm introduction beats a cold email. Get matched and request an intro.

Featured In

Browse More Investors

Fundraising resources

Frequently Asked Questions

See if Catalio Capital Management is a match for your startup

Upload your pitch deck to see how well you match with Catalio Capital Management and 10,000+ other investors.

Ask your AI assistant about this investor: connect InvestorMatch to Claude or ChatGPT

Is this your profile? Request a correction or removal